CU Medicine identifies a “fish allergenicity ladder” system, promoting evidence-based, personalised seafood avoidance for patients with fish allergy

CU Medicine’s nationwide multicentre study on acute lymphoblastic leukaemia establishes a new biomarker to inform relapse risk and treatment strategies

CU Medicine finds surgical treatment lowers blood pressure in children with severe obstructive sleep apnoea but postoperative weight control is equally important

CU Medicine study identifies 11 allergen components of shrimp for precision diagnosis of shrimp allergy

CUHK unravels the world’s most comprehensive genome profile of the American cockroach and reveals novel cockroach allergens for the development of precision immunotherapy

CUHK’s HK-HOPE develops an integrated drug and genomic test to tailor precision personalised medicine and deliver “hope” to children with difficult-to-treat leukaemia

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

CU Medicine proves basophil activation test has much higher diagnostic accuracy for shrimp allergy than conventional allergy tests

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

CU Medicine Study Shows Childhood Obstructive Sleep Apnoea Increases the Risk of Hypertension in Adulthood

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”